Publisher
Springer International Publishing
Reference57 articles.
1. Agarwal C, Wadhwa R, Deep G, Biedermann D, Gazak R, Kren V, Agarwal R (2013) Anti-cancer efficacy of silybin derivatives—a structure-activity relationship. PLoS One 8:e60074
2. Bang CI, Paik SY, Sun DI, Joo YH, Kim MS (2008) Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol 117:781–785
3. Bousserouel S, Bour G, Kauntz H, Gosse F, Marescaux J, Raul F (2012) Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway. Anticancer Res 32:2455–2462
4. Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH (2010) Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 291:120–129
5. Cheung CW, Gibbons N, Johnson DW, Nicol DL (2010) Silibinin-a promising new treatment for cancer. Anticancer Agents Med Chem 10:186–195